Recombinant Shiga Toxin B Subunit Can Induce Neutralizing Immunoglobulin Y Antibody-Reference-Cited by-同舟云学术

Recombinant Shiga Toxin B Subunit Can Induce Neutralizing Immunoglobulin Y Antibody

Published:2012 Issue:6 Volume:35 Page:917-923
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Neri Paola¹,Tokoro Shunji¹,Sugiyama Tsuyoshi¹,Umeda Kouji²,Shimizu Takeshi³,Tsuji Takao⁴,Kodama Yoshikatsu²,Mori Hiroshi¹

Affiliation:

1. Microbiology, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University

2. Immunology Research Institute, GHEN Corporation

3. Department of Molecular Infectiology, Graduate School of Medicine, Chiba University

4. Department of Microbiology, School of Medicine, Fujita Health University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/35/6/35_b12-00008/_pdf

Reference37 articles.

1. 1) Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev., 11, 450–479 (1998).

2. 2) Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, De Grandis S, Karmali M. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem., 262, 8834–8839 (1987).

3. 3) Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem., 171, 45–50 (1988).

4. 4) Mulvey GL, Marcato P, Kitov PI, Sadowska J, Bundle DR, Armstrong GD. Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. J. Infect. Dis., 187, 640–649 (2003).

5. 5) Watanabe M, Matsuoka K, Kita E, Igai K, Higashi N, Miyagawa A, Watanabe T, Yanoshita R, Samejima Y, Terunuma D, Natori Y, Nishikawa K. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections. J. Infect. Dis., 189, 360–368 (2004).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production of egg yolk antibody (IgY) against shiga-like toxin (stx) and evaluation of its prophylaxis potency in mice;Microbial Pathogenesis;2020-08

2. Clinical efficacy of oral immunoglobulin Y in infant rotavirus enteritis;Medicine;2019-07

3. Egg Yolk Immunoglobulin Supplementation Prevents Rat Liver from Aflatoxin B1-Induced Oxidative Damage and Genotoxicity;Journal of Agricultural and Food Chemistry;2018-11-17

4. IgY Reduces AFB1-Induced Cytotoxicity, Cellular Dysfunction, and Genotoxicity in Human L-02 Hepatocytes and Swan 71 Trophoblasts;Journal of Agricultural and Food Chemistry;2018-01-31

5. Chicken Egg Yolk Antibodies (IgY) for Prophylaxis and Treatment of Rotavirus Diarrhea in Human and Animal Neonates: A Concise Review;Korean Journal for Food Science of Animal Resources;2017-02-28